Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure
- All allowable shares were placed successfully
- Strategic partner Huadong becomes second largest shareholder
Heidelberg Pharma AG today successfully completed the capital measure adopted on 12 August 2022 and generates gross issue proceeds of approximately EUR 80 million by placing all new shares.